Related Experiment Video
Updated: Aug 12, 2026

04:48
Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
3.1K
Development of bacteriostatic central venous port using photobiomodulation: a comparative in vitro study
Yuki Takara1, Daisuke Yunaiyama2, Mika Yasutomi2
1Department of Radiology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjukuku, Tokyo, 160-0023, Japan. y-takara@tokyo-med.ac.jp.
Lasers in Medical Science
|October 17, 2024
Summary
Photobiomodulation (PBM) using red light effectively inhibited methicillin-resistant Staphylococcus aureus (MRSA) growth in vitro. This study supports PBM
Area of Science:
- Biomedical Engineering
- Infectious Diseases
- Photomedicine
Background:
- Central venous (CV) infections are often caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Novel central venous ports (CVPs) utilizing light-emitting diodes (LEDs) for photobiomodulation (PBM) offer a potential preventative strategy.
- PBM involves exposing cells to low-intensity light to elicit therapeutic effects.
Purpose of the Study:
- To investigate the in vitro efficacy of PBM with 680 nm red light in reducing MRSA growth.
- To evaluate the impact of varying irradiation durations on MRSA colony counts.
Main Methods:
- MRSA suspensions were irradiated with 680 nm red light for 7.5, 15, 30, or 60 minutes.
- Colony counts were determined post-incubation and compared between irradiated and control groups.
- Statistical analysis included Shapiro-wilk test, one-factor ANOVA, and Bonferroni's post-hoc test.
Main Results:
- Irradiation for 30 and 60 minutes significantly reduced MRSA colony counts compared to the control group.
- The 60-minute irradiation group showed a significant reduction compared to the control, 7.5-minute, and 15-minute groups.
- Significant differences were observed between control and 30/60-minute groups, and between 7.5/15-minute and 60-minute groups.
Conclusions:
- Photobiomodulation with 680 nm LEDs demonstrates significant inhibitory effects on MRSA growth in vitro.
- PBM applied to a central venous port shows promise for preventing central venous access port-blood stream infections.
- Further research into PBM applications for combating device-related infections is warranted.

